Days 1+2 of Cell & Gene Meeting on the Mesa have provided great insights on what’s in store for gene therapy. Dyno CEO and Founder Eric Kelsic sat down with Inside Precision Medicine's Jonathan D. Grinstein, PhD to talk about how improved gene delivery will be crucial to bringing gene therapies to market. Check it out: #CGMesa24 #GeneTherapy
The theme from D1 Cell and Gene Meeting on the Mesa (Alliance for Regenerative Medicine) was about coming down to earth & atomizing the commercialization and industrialization problems of cell and gene therapy into attainable building blocks. Check out my convos w/ Dyno Therapeutics, Profluent, Astellas Gene Therapies / Astellas Pharma, Autolomous. Stay cool!